Javascript must be enabled to continue!
Liver Fibrosis: Interactions Between Cells and Microenvironments
View through CrossRef
Liver fibrosis is a key intermediate stage in the progression of chronic liver disease to end-stage liver cirrhosis. Mortality rises exponentially once it reaches decompensated liver disease. In a healthy liver microenvironment, hepatocytes, Kupffer cells, hepatic stellate cells (HSCs), liver sinusoidal endothelial cells, and other cells interact with extracellular matrix (ECM) to maintain cell stability and liver function. Different types of liver injury (such as viral hepatitis and alcoholic liver injury) can cause liver fibrosis. Liver injury signals activate Kupffer cells and recruit immune cells, leading to liver inflammation. This inflammation, together with liver injury, stimulates the activation of HSCs. Activated HSCs migrate to injury sites and secrete ECM. The ECM increase and stiffening contribute to fibrosis. Microenvironment changes alter cell phenotypesperpetuating HSC activation. This article explores liver fibrosis mechanisms, reviews cellular and microenvironmental changes, summarizes fibrosis characteristics, and provides insights for clinical treatment.
Cite this article as: Zou X, Ke Y, Shao Y, Liu S, Shi T. Liver fibrosis: interactions between cells and microenvironments. Turk J Gastroenterol. 2025;36(11):711-722.
AVES YAYINCILIK A.Ş.
Title: Liver Fibrosis: Interactions Between Cells and Microenvironments
Description:
Liver fibrosis is a key intermediate stage in the progression of chronic liver disease to end-stage liver cirrhosis.
Mortality rises exponentially once it reaches decompensated liver disease.
In a healthy liver microenvironment, hepatocytes, Kupffer cells, hepatic stellate cells (HSCs), liver sinusoidal endothelial cells, and other cells interact with extracellular matrix (ECM) to maintain cell stability and liver function.
Different types of liver injury (such as viral hepatitis and alcoholic liver injury) can cause liver fibrosis.
Liver injury signals activate Kupffer cells and recruit immune cells, leading to liver inflammation.
This inflammation, together with liver injury, stimulates the activation of HSCs.
Activated HSCs migrate to injury sites and secrete ECM.
The ECM increase and stiffening contribute to fibrosis.
Microenvironment changes alter cell phenotypesperpetuating HSC activation.
This article explores liver fibrosis mechanisms, reviews cellular and microenvironmental changes, summarizes fibrosis characteristics, and provides insights for clinical treatment.
Cite this article as: Zou X, Ke Y, Shao Y, Liu S, Shi T.
Liver fibrosis: interactions between cells and microenvironments.
Turk J Gastroenterol.
2025;36(11):711-722.
Related Results
Modern Principles of Liver Fibrosis Diagnosis in Patients With Chronic Diffuse Liver Lesions: Literature Review and Clinical Case Description
Modern Principles of Liver Fibrosis Diagnosis in Patients With Chronic Diffuse Liver Lesions: Literature Review and Clinical Case Description
Introduction. Chronic diffuse liver lesions, which is at a certain stage and phase of the disease characterized by excessive accumulation of components of the extracellular matrix,...
Initial study of biexponential model of intravoxel incoherent motion magnetic resonance imaging in evaluation of the liver fibrosis
Initial study of biexponential model of intravoxel incoherent motion magnetic resonance imaging in evaluation of the liver fibrosis
Background
The diagnosis of liver fibrosis is a difficult task at any time using conventional clinical imaging. Intravoxel incoherent motion (IVIM) can be used to inves...
Effect of Qizhu Granule on Liver Sinusoidal Endothelial Cells Capillarization in Carbon Tetrachloride-Induced Rats Fibrosis.
Effect of Qizhu Granule on Liver Sinusoidal Endothelial Cells Capillarization in Carbon Tetrachloride-Induced Rats Fibrosis.
Abstract
Background: Qizhu granule, a traditional Chinese medicine, has been widely used in clinic as a complementary and alternative medicine to treat liver fibrosis.Howev...
Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity
Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity
Bromodomain-containing protein 4 (BRD4) has been implicated to play a regulatory role in fibrogenic gene expression in animal models of liver fibrosis. The potential role of BRD4 i...
B1a cells protect againstSchistosoma japonicum–induced liver inflammation and fibrosis by controlling monocyte infiltration
B1a cells protect againstSchistosoma japonicum–induced liver inflammation and fibrosis by controlling monocyte infiltration
AbstractDuringSchistosomainfection, lack of B cells results in more severe granulomas, inflammation, and fibrosis in the liver, but the mechanisms underlying this pathology remain ...
CORRELATION BETWEEN SERUM LIVER ENZYMES AND FIBROSIS SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS. A CROSS-SECTIONAL STUDY
CORRELATION BETWEEN SERUM LIVER ENZYMES AND FIBROSIS SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS. A CROSS-SECTIONAL STUDY
Background: One of the major chronic liver diseases in the world is NAFLD which tends to start as mere steatosis but tends to evolve into fibrosis and cirrhosis. Serum liver enzyme...
Anti-inflammatory and Antifibrotic Effects of Harpullia cupanioides L. Leaves in Thioacetamide-Induced Liver Fibrosis in Rats
Anti-inflammatory and Antifibrotic Effects of Harpullia cupanioides L. Leaves in Thioacetamide-Induced Liver Fibrosis in Rats
Introduction:
Inflammation is mainly caused by cellular and vascular factors. Lymphocytes and macrophages
are among the circulating cellular constituents. It is...
A bioactive product lipoxin A4 attenuates liver fibrosis in an experimental model by regulating immune response and modulating the expression of regeneration genes
A bioactive product lipoxin A4 attenuates liver fibrosis in an experimental model by regulating immune response and modulating the expression of regeneration genes
Background/Aims: Lipoxin A4 (LXA4), an anti-inflammatory lipid mediator, regulates leukocyte cellular activity and activates gene transcription. The therapeutic effect of LXA4 on l...

